Biomol Ther 2019; 27(2): 127-133  https://doi.org/10.4062/biomolther.2018.183
Streptomyces Cytochrome P450 Enzymes and Their Roles in the Biosynthesis of Macrolide Therapeutic Agents
Myung-A Cho, Songhee Han, Young-Ran Lim, Vitchan Kim, Harim Kim and Donghak Kim*
Department of Biological Sciences, Konkuk University, Seoul 05025, Republic of Korea
E-mail: donghak@konkuk.ac.kr
Tel: +82-2-450-3366, Fax: +82-2-3436-5432
Received: September 20, 2018; Revised: October 8, 2018; Accepted: October 8, 2018; Published online: December 18, 2018.
© The Korean Society of Applied Pharmacology. All rights reserved.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
The study of the genus Streptomyces is of particular interest because it produces a wide array of clinically important bioactive molecules. The genomic sequencing of many Streptomyces species has revealed unusually large numbers of cytochrome P450 genes, which are involved in the biosynthesis of secondary metabolites. Many macrolide biosynthetic pathways are catalyzed by a series of enzymes in gene clusters including polyketide and non-ribosomal peptide synthesis. In general, Streptomyces P450 enzymes accelerate the final, post-polyketide synthesis steps to enhance the structural architecture of macrolide chemistry. In this review, we discuss the major Streptomyces P450 enzymes research focused on the biosynthetic processing of macrolide therapeutic agents, with an emphasis on their biochemical mechanisms and structural insights.
Keywords: Streptomyces, P450, CYP, Biosynthesis, Macrolide, Secondary metabolite


This Article


Cited By Articles
  • CrossRef (0)

Funding Information

Services
Social Network Service

e-submission

Archives